J. Keski‐Oja

J. Keski‐Oja, K. Koli, J. Keski‐oja, 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate.

J. Westermarck, V. Kähäri, J. Keski‐Oja, 1996, European journal of biochemistry.

Calcium Ionophores Decrease Pericellular Gelatinolytic Activity via Inhibition of 92-kDa Gelatinase Expression and Decrease of 72-kDa Gelatinase Activation (*)

J. Keski‐Oja, J. Lohi, J. Keski‐oja, 1995, The Journal of Biological Chemistry.

Okadaic acid-elicited transcriptional activation of collagenase gene expression in HT-1080 fibrosarcoma cells is mediated by JunB.

J. Westermarck, V. Kähäri, J. Keski‐Oja, 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Cyclosporin A enhances cytokine and phorbol ester-induced fibroblast collagenase expression.

V. Kähäri, J. Keski‐Oja, J. Lohi, 1994, The Journal of investigative dermatology.

Specific sequence motif of 8-Cys repeats of TGF-beta binding proteins, LTBPs, creates a hydrophobic interaction surface for binding of small latent TGF-beta.

J. Keski‐Oja, J. Saharinen, J. Keski‐oja, 2000, Molecular biology of the cell.

Pneumonia aeruginosa Pseudomonas Macrophage Recruitment in Epilysin (MMP-28) Restrains Early

T. Betsuyaku, W. Parks, J. Keski‐Oja, 2009 .

Epilysin (MMP-28) Restrains Early Macrophage Recruitment in Pseudomonas aeruginosa Pneumonia1

T. Betsuyaku, W. Parks, J. Keski‐Oja, 2009, The Journal of Immunology.

An Endostatin-derived Peptide Interacts with Integrins and Regulates Actin Cytoskeleton and Migration of Endothelial Cells*

K. Alitalo, J. Keski‐Oja, S. Wickström, 2004, Journal of Biological Chemistry.

Murine sarcoma growth factors affect the growth and morphology of cultured mouse epithelial cells

U. Rapp, J. Keski‐Oja, G. Todaro, 1980, Journal of cellular physiology.

Secretion of human latent TGF-beta-binding protein-3 (LTBP-3) is dependent on co-expression of TGF-beta.

J. Keski‐Oja, J. Saharinen, Krista Weikkolainen, 2002, Journal of cell science.

Activation of paracrine TGF‐β1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase

J. Keski‐Oja, P. Kovanen, K. Lindstedt, 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Fibronectin and viral pathogenesis.

J. Keski‐Oja, I. Julkunen, A. Hautanen, 1987, Reviews of infectious diseases.

Human Endothelial Cells in Activates Src via a Tyrosyl Phosphatase-dependent Pathway 1 and Caveolin-1, and β 5 α Endostatin Associates with Integrin

K. Alitalo, J. Keski‐Oja, S. Wickström, 2013 .

Vitamin D receptor polymorphism and treatment of psoriasis with calcipotriol

J. Keski‐Oja, K. Kontula, K. Kainulainen, 1997, The British journal of dermatology.

Vitamin D3 regulation of transforming growth factor-beta system in epithelial and fibroblastic cells--relationships to plasminogen activation.

J. Keski‐Oja, K. Koli, 1996, The journal of investigative dermatology. Symposium proceedings.

Vitamin D3 and Calcipotriol Enhance the Secretion of Transforming Growth Factor-β1 and -β2 in Cultured Murine Keratinocytes

J. Keski‐Oja, K. Koli, J. Keski‐oja, 1993 .

A Review of its Pharmacological Properties and Therapeutic Efficacy in the Management of Psoriasis

J. Keski‐Oja, L. Kemény, M. Bagot, 1996 .

Novel non-TGF-beta-binding splice variant of LTBP-4 in human cells and tissues provides means to decrease TGF-beta deposition.

J. Keski‐Oja, J. Saharinen, K. Koli, 2001, Journal of Cell Science.

Disruption of LTBP-4 function reduces TGF- (cid:1) activation and enhances BMP-4 signaling in the lung

H. V. Melchner, W. Hofmann, J. Keski‐Oja, 2004 .

Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation.

J. Keski‐Oja, M. Hyytiäinen, C. Penttinen, 2004, Critical reviews in clinical laboratory sciences.

Disruption of LTBP-4 function reduces TGF-β activation and enhances BMP-4 signaling in the lung

H. von Melchner, W. Hofmann, J. Keski‐Oja, 2004, The Journal of cell biology.

Latent TGF-beta binding proteins (LTBPs)-1 and -3 coordinate proliferation and osteogenic differentiation of human mesenchymal stem cells.

J. Keski‐Oja, K. Koli, M. Ryynänen, 2008, Bone.

Release of transforming growth factor-beta 1 from the pericellular matrix of cultured fibroblasts and fibrosarcoma cells by plasmin and thrombin.

J. Taipale, J. Keski‐Oja, K. Koli, 1992, The Journal of biological chemistry.

Proteolytic processing of the 72,000-Da type IV collagenase by urokinase plasminogen activator.

J. Keski‐Oja, K. Tryggvason, A. Tuuttila, 1992, Experimental cell research.

Structure and expression of type IV collagenase genes.

L. Chow, J. Keski‐Oja, K. Tryggvason, 1990, Cell differentiation and development : the official journal of the International Society of Developmental Biologists.

Transforming growth factor beta

J. Keski‐Oja, K. Koli, J. Keski‐oja, 2015 .

Human Mast Cell Chymase and Leukocyte Elastase Release Latent Transforming Growth Factor-β1 from the Extracellular Matrix of Cultured Human Epithelial and Endothelial Cells (*)

J. Taipale, J. Keski‐Oja, P. Kovanen, 1995, The Journal of Biological Chemistry.

Modulation of TGF-beta activity by latent TGF-beta-binding protein 1 in human malignant glioma cells

D. Capper, J. Keski‐Oja, J. Saharinen, 2009 .

Transforming growth factors-beta as regulators of cellular growth and phenotype.

M. Laiho, J. Keski‐Oja, J. Keski‐oja, 1992, Critical reviews in oncogenesis.

Synthesis and degradation of connective tissue macromolecules in pachydermoperiostosis (PDF): evidence for altered processing of plasminogen activator inhibitor‐1 (PAI‐1)

J. Keski‐Oja, A. Oikarinen, R. Palatsi, 1995, Experimental dermatology.

Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells – role in metastasis

L. Liotta, T. Salo, J. Keski‐Oja, 1982, International journal of cancer.

Enhancement of vitronectin expression in human HepG2 hepatoma cells by transforming growth factor-beta 1.

J. Keski‐Oja, A. Hautanen, K. Koli, 1991, European journal of biochemistry.

Isolation of Chlamydia trachomatis in Untreated MMC-E mouse epithelial cells

J. Keski‐Oja, J. Paavonen, 1982, Journal of clinical microbiology.

Cerebrospinal fluid IgG bands and virus-specific IgG, IgM, and IgA antibodies in herpes simplex virus encephalitis

A. Vaheri, J. Keski‐Oja, E. Salonen, 1982, Journal of Neuroimmunology.

Cross-linking of a major fibroblast surface-associated glycoprotein (fibronectin) catalyzed by blood coagulation factor XIII

A. Vaheri, J. Keski‐Oja, D. Mosher, 1976, Cell.

1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor beta 1 and its latent form binding protein in cultured breast carcinoma cells.

J. Keski‐Oja, K. Koli, J. Keski‐oja, 1995, Cancer research.

Ephrin‐As, Eph receptors and integrin α3 interact and colocalise at membrane protrusions of U251MG glioblastoma cells

T. Nyman, J. Keski‐Oja, Irene Ylivinkka, 2013, Cell biology international.

FIBRONECTIN AND THE PERICELLULAR MATRIX OF NORMAL AND TRANSFORMED ADHERENT CELLS *

K. Alitalo, A. Vaheri, J. Keski‐Oja, 1978, Annals of the New York Academy of Sciences.

Vitamin D3 and calcipotriol decrease extracellular plasminogen activator activity in cultured keratinocytes.

J. Keski‐Oja, K. Koli, J. Keski‐oja, 1993, The Journal of investigative dermatology.

Vitamin D3 derivatives (deltanoids) in the treatment of tumor cell invasion.

J. Keski‐Oja, 1999, The Journal of laboratory and clinical medicine.

Amplification of Cellular Oncogenes in Colon and Lung Cancer Cells

K. Alitalo, R. Winqvist, J. Keski‐Oja, 1985 .

Human fibrosarcoma cells produce fibronectin-releasing peptides.

J. Keski‐Oja, G. Todaro, H. Marquardt, 1979, Journal of supramolecular structure.

Co-recycling of MT1-MMP and MT3-MMP through the Trans-Golgi Network

J. Keski‐Oja, D. Pei, D. Ma, 2004, Journal of Biological Chemistry.

Enhanced junGeneExpression IsanEarlyGenomicResponse to Transforming GrowthFactor ,BStimulation

L. Sistonen, J. Keski‐Oja, J. Keski‐oja, 1989 .

The cellular target for the plasminogen activator, urokinase, in human fibroblasts - 66 000 dalton protein.

A. Vaheri, J. Keski‐Oja, J. Keski‐oja, 1982, Biochimica et biophysica acta.

Micromethod for detection of oligoclonal IgG in unconcentrated CSF by polyacrylamide gel electrophoresis.

J. Selhorst, J. Keski‐Oja, J. Sever, 1981, Archives of neurology.

Localization of viral-envelope-glycoprotein-binding sites in fibronectin.

J. Keski‐Oja, I. Julkunen, T. Vartio, 1984, The Biochemical journal.

Regulation of plasminogen activator activity in human fibroblastic cells by fibrosarcoma cell-derived factors.

M. Laiho, J. Keski‐Oja, O. Saksela, 1985, Cancer research.

PDGF-BB Induces Expression of LTBP-1 but not TGF-β1 in a Rat Cirrhotic Fat Storing Cell Line

A. Gressner, J. Keski‐Oja, K. Breitkopf, 2003, Growth factors.

Expression and purification of soluble and inactive mutant forms of membrane type 1 matrix metalloproteinase.

J. Keski‐Oja, K. Lehti, J. Lohi, 2000, Protein expression and purification.

Oligomerization through Hemopexin and Cytoplasmic Domains Regulates the Activity and Turnover of Membrane-type 1 Matrix Metalloproteinase*

J. Keski‐Oja, K. Lehti, D. Pei, 2002, The Journal of Biological Chemistry.

Terminology for Medical In Vitro Cell Biology

A. Schousboe, E. Pettersen, J. Denekamp, 2000 .

Hypoxia, normoxia and hyperoxia--terminology for medical in vitro cell biology.

A. Schousboe, O. Amellem, E. Pettersen, 2000, Acta oncologica.

Transforming growth factor‐β does not alter interleukin‐1 expression in cultured human macrophages

K. Alitalo, J. Keski‐Oja, M. Hurme, 1989, Journal of cellular biochemistry.

Apoptosis of human endothelial cells is accompanied by proteolytic processing of latent TGF-beta binding proteins and activation of TGF-beta.

J. Keski‐Oja, V. Solovyan, 2005, Cell death and differentiation.

Impaired migration and delayed differentiation of pancreatic islet cells in mice lacking EGF-receptors.

J. Keski‐Oja, E. Lehtonen, T. Otonkoski, 2000, Development.

Association of Latent Transforming Growth Factor-β to Fibroblast Extracellular Matrix

J. Taipale, J. Keski‐Oja, J. Saharinen, 1995 .

Transforming growth factors and control of neoplastic cell growth

R. Coffey, H. Moses, J. Keski‐Oja, 1987, Journal of cellular biochemistry.

Growth factors in the regulation of pericellular proteolysis: a review.

M. Laiho, J. Keski‐Oja, J. Keski‐oja, 1989, Cancer research.

Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium

H. Moses, J. Keski‐Oja, R. Lyons, 1988, The Journal of cell biology.

Plasmin activates pro‐matrix metalloproteinase‐2 with a membrane‐type 1 matrix metalloproteinase‐dependent mechanism

J. Keski‐Oja, K. Lehti, Jorma Keski-Oja, 2002, Journal of cellular physiology.

Direct association of fibronectin and actin molecules in vitro

J. Keski‐Oja, G. Todaro, A. Sen, 1980, The Journal of cell biology.

Active and latent forms of transforming growth factor beta activity in synovial effusions

T. Pincus, N. Olsen, H. Moses, 1989, The Journal of experimental medicine.

Inhibition of morphogenesis and stimulation of vascular proliferation in embryonic tooth cultures by a sarcoma growth factor preparation.

I. Thesleff, J. Keski‐Oja, P. Ekblom, 1983, Cancer research.

Transforming growth factors in the regulation of malignant cell growth and invasion.

H. Moses, J. Keski‐Oja, A. Postlethwaite, 1988, Cancer investigation.

Cutis laxa in hereditary gelsolin amyloidosis

S. Kiuru-Enari, J. Keski‐Oja, M. Haltia, 2005, The British journal of dermatology.

Effects of Zn2+ ions on protein phosphorylation in epithelial cell membranes

K. Alitalo, P. Bornstein, J. Keski‐Oja, 1983, Journal of cellular physiology.

Growth control in chick embryo fibroblasts; no evidence for a specific role for cyclic purine nucleotides.

A. Vaheri, J. Keski‐Oja, T. Hovi, 1974, Cell.

Transforming growht factor β1 and its latent form binding protein‐1 associate with elastic fibres in human dermis: accumulation in actinic damage and absence in anetoderma

J. Keski‐Oja, T. Karonen, L. Jeskanen, 1997, The British journal of dermatology.

Pachydermoperiostosis: analysis of the connective tissue abnormality in one family.

J. Risteli, M. Kallioinen, A. Oikarinen, 1994, Journal of the American Academy of Dermatology.

Latent TGF-β binding protein LTBP-2 decreases fibroblast adhesion to fibronectin

J. Keski‐Oja, M. Hyytiäinen, J. Keski‐oja, 2003, The Journal of cell biology.

Rapid release of fibronectin from human lung fibroblasts by biologically active phorbol esters

J. Keski‐Oja, G. Todaro, J. D. De Larco, 1979, International journal of cancer.

Latent TGF-β Binding Proteins: Extracellular Matrix Association and Roles in TGF-β Activation

J. Keski‐Oja, M. Hyytiäinen, C. Penttinen, 2004 .

Latency, activation, and binding proteins of TGF‐β

J. Keski‐Oja, J. Saharinen, K. Koli, 2001, Microscopy research and technique.

Interactions of Fibronectin, a Cell-Type Specific Surface-Associated Glycoprotein

A. Vaheri, J. Keski‐Oja, D. Mosher, 1977 .

Regulation of the synthesis and activity of urokinase plasminogen activator in A549 human lung carcinoma cells by transforming growth factor-beta

H. Moses, J. Keski‐Oja, F. Blasi, 1988, The Journal of cell biology.

Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas

J. Keski‐Oja, K. Lehti, U. Saarialho-Kere, 1999, British Journal of Cancer.

Transforming growth factor β alters plasminogen activator activity in human skin fibroblasts

M. Laiho, J. Keski‐Oja, O. Saksela, 1986 .

Fibroblast surface antigen (SF): molecular properties, distribution in vitro and in vivo, and altered expression in transformed cells.

E. Ruoslahti, A. Vaheri, J. Keski‐Oja, 1976, Journal of supramolecular structure.

PericellularMatrix and Cell Surface Glycoproteinsof Virus transformedMouse EpithelialCells' of the regulation of cell growth and

K. Alitalo, C. Gahmberg, J. Keski‐Oja, 2006 .

Transformation of MMC‐E epithelial cells by acute 3611‐MSV: inhibition of collagen synthesis and induction of novel polypeptides

A. Vaheri, U. Rapp, J. Keski‐Oja, 1982, Journal of cellular biochemistry.

Dimeric character of fibronectin, a major cell surface-associated glycoprotein.

A. Vaheri, J. Keski‐Oja, D. Mosher, 1977, Biochemical and biophysical research communications.

MT1-MMP releases latent TGF-beta1 from endothelial cell extracellular matrix via proteolytic processing of LTBP-1.

J. Keski‐Oja, K. Lehti, P. Vehviläinen, 2008, Experimental cell research.

Thrombin affects fibronectin and procollagen in the pericellular matrix of cultured human fibroblasts.

A. Vaheri, J. Keski‐Oja, G. Todaro, 1981, Biochimica et biophysica acta.

Specific effects of fibronectin-releasing peptides on the extracellular matrices of cultured human fibroblasts.

J. Keski‐Oja, G. Todaro, J. Keski‐oja, 1980, Cancer research.

Human ectocervical and endocervical epithelial cells in culture: a comparative ultrastructural study.

J. Keski‐Oja, J. Carson, J. Pagano, 1980, American journal of obstetrics and gynecology.

Fibroblast surface antigen (SF): THE external glycoprotein lost in proteolytic stimulation and malignant transformation

E. Ruoslahti, A. Vaheri, J. Keski‐Oja, 1976, International journal of cancer.

Induction of fibroblast chemotaxis by fibronectin. Localization of the chemotactic region to a 140,000-molecular weight non-gelatin-binding fragment

G. Balian, J. Keski‐Oja, A. Kang, 1981, The Journal of experimental medicine.

Distribution of a major surface-associated glycoprotein, fibronectin, in cultures of adherent cells.

A. Vaheri, J. Keski‐Oja, D. Mosher, 1977, Journal of supramolecular structure.

EFFECTS OF THROMBIN, OTHER PROTEASES AND MALIGNANT TRANSFORMATION ON THE MAJOR CELL SURFACE-ASSOCIATED GLYCOPROTEIN, FIBRONECTIN

A. Vaheri, J. Keski‐Oja, D. Mosher, 1978 .

Transforming growth factor-beta induction of type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase.

M. Laiho, J. Keski‐Oja, O. Saksela, 1987, The Journal of biological chemistry.

Rapid membrane changes in mouse epithelial cells after exposure to epidermal growth factor.

U. Heine, J. Keski‐Oja, B. Wetzel, 1981, Journal of ultrastructure research.

Netrin-4 Promotes Glioblastoma Cell Proliferation through Integrin Β 4 Signaling 1,2

S. Hautaniemi, T. Nyman, J. Keski‐Oja, 2012 .

Truncal telangiectases coinciding with felodipine.

J. Keski‐Oja, S. Stubb, T. Karonen, 1998, Dermatology.

Epilysin (MMP-28) induces TGF-β mediated epithelial to mesenchymal transition in lung carcinoma cells

J. Keski‐Oja, K. Lehti, J. Lohi, 2006, Journal of Cell Science.

Epilysin (MMP-28) expression is associated with cell proliferation during epithelial repair.

J. Keski‐Oja, E. Kerkelä, T. Jahkola, 2002, The Journal of investigative dermatology.

FGF receptor-4 (FGFR4) polymorphism acts as an activity switch of a membrane type 1 matrix metalloproteinase–FGFR4 complex

Jussi Taipale, Markku Varjosalo, K. Alitalo, 2010, Proceedings of the National Academy of Sciences.

ACUTE MYELOGENOUS LEUKAEMIA WITH C-MYC AMPLIFICATION AND DOUBLE MINUTE CHROMOSOMES

A. Chapelle, S. Knuutila, K. Alitalo, 1985, The Lancet.

Isolation of an actin-binding fragment of fibronectin.

K. Yamada, J. Keski‐Oja, J. Keski‐oja, 1981, The Biochemical journal.

Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer.

J. Otte, I. Thorey, H. von Melchner, 2002, Genes & development.

Secretion of human latent TGF-β-binding protein-3 (LTBP-3) is dependent on co-expression of TGF-β

J. Keski‐Oja, J. Saharinen, Krista Weikkolainen, 2002 .

Novel non-TGF-β-binding splice variant of LTBP-4 in human cells and tissues provides means to decrease TGF-β deposition

J. Keski‐Oja, J. Saharinen, K. Koli, 2001 .

Specific Sequence Motif of 8-Cys Repeats of TGF-β Binding Proteins, LTBPs, Creates a Hydrophobic Interaction Surface for Binding of Small Latent TGF-β

Juha Saharinen, J. Keski‐Oja, J. Saharinen, 2000 .

Latent transforming growth factor-beta binding proteins (LTBPs)--structural extracellular matrix proteins for targeting TGF-beta action.

J. Taipale, J. Keski‐Oja, J. Saharinen, 1999, Cytokine & growth factor reviews.

Extracellular matrix-associated transforming growth factor-beta: role in cancer cell growth and invasion.

J. Taipale, J. Keski‐Oja, J. Saharinen, 1998, Advances in cancer research.

Dose effects of transfected c-Ha-rasVal 12 oncogene in transformed cell clones.

K. Alitalo, L. Sistonen, E. Hölttä, 1987, Experimental cell research.

Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.

J. Keski‐Oja, K. Lehti, J. Lohi, 1998, The Biochemical journal.

The ECM protein LTBP‐2 is a suppressor of esophageal squamous cell carcinoma tumor formation but higher tumor expression associates with poor patient outcome

S. Law, Q. Tao, K. Chan, 2011, International journal of cancer.

FAST TRACK Modulation of TGF-b activity by latent TGF-b-binding protein 1 in human malignant glioma cells

M. Weller, W. Wick, D. Capper, 2009 .

Modulation of TGF‐β activity by latent TGF‐β‐binding protein 1 in human malignant glioma cells

M. Weller, W. Wick, D. Capper, 2009, International journal of cancer.

Asbestos exposure induces alveolar epithelial cell plasticity through MAPK/Erk signaling

J. Keski‐Oja, M. Myllärniemi, K. Koli, 2012, Journal of cellular biochemistry.

Epilysin (MMP‐28) – structure, expression and potential functions

J. Keski‐Oja, J. Lohi, S. Illman, 2008, Experimental dermatology.

Latent transforming growth factor-beta 1 and its binding protein are components of extracellular matrix microfibrils.

J. Taipale, J. Keski‐Oja, J. Saharinen, 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein

K. Miyazono, C. Heldin, J. Taipale, 1994, The Journal of cell biology.

Apoptosis of human endothelial cells is accompanied by proteolytic processing of latent TGF-β binding proteins and activation of TGF-β

J. Keski‐Oja, V. Solovyan, J. Keski‐oja, 2005, Cell Death and Differentiation.

Murine leukemia virus-mediated transformation of a mouse epithelial cell line MMC-E.

U. Rapp, J. Keski‐Oja, J. Keski‐oja, 1982, Cancer research.

Netrin-1: A regulator of cancer cell motility?

J. Keski‐Oja, Irene Ylivinkka, M. Hyytiäinen, 2016, European journal of cell biology.

Endostatin signaling and regulation of endothelial cell-matrix interactions.

K. Alitalo, J. Keski‐Oja, S. Wickström, 2005, Advances in cancer research.

Growth Factors in the Regulation of Plasminogen-Plasmin System in Tumor Cells

M. Laiho, J. Keski‐Oja, K. Koli, 1991, Seminars in thrombosis and hemostasis.

Endostatin Associates with Lipid Rafts and Induces Reorganization of the Actin Cytoskeleton via Down-regulation of RhoA Activity*

K. Alitalo, J. Keski‐Oja, S. Wickström, 2003, Journal of Biological Chemistry.

Ang‐2 upregulation correlates with increased levels of MMP‐9, VEGF, EPO and TGFβ1 in diabetic eyes undergoing vitrectomy

I. Immonen, M. Jauhiainen, J. Keski‐Oja, 2013, Acta ophthalmologica.

Transforming growth factor-beta system and its regulation by members of the steroid-thyroid hormone superfamily.

J. Keski‐Oja, K. Koli, J. Keski‐oja, 1996, Advances in cancer research.

Growth stimulation, altered regulation of epidermal growth factor receptors, and autocrine transformation of spontaneously transformed normal rat kidney cells by transforming growth factor beta.

M. J. Newman, M. Nugent, H. Moses, 1989, Cancer research.

Regulation of TGF-β storage and activation in the human idiopathic pulmonary fibrosis lung

K. Salmenkivi, J. Keski‐Oja, V. Kinnula, 2012, Cell and Tissue Research.

Expression of latent TGF-beta binding protein LTBP-1 is hormonally regulated in normal and transformed human lung fibroblasts.

J. Keski‐Oja, K. Koli, Krista Weikkolainen, 2003, Growth Factors.

Immunodetection and modulation of cellular growth with antibodies against native transforming growth factor-beta 1.

H. Moses, J. Keski‐Oja, R. Lyons, 1987, Cancer research.

Biological Functions of Latent TGF-β-Binding Proteins and Activation of TGF-β

J. Keski‐Oja, K. Koli, M. Hyytiäinen, 2008 .

Transforming growth factor-ßs as modulators of pericellular proteolytic events

M. Laiho, J. Keski‐Oja, J. Lohi, 1989, Cytotechnology.

Induction of transforming growth factor beta 1 and its receptor expression during myeloid leukemia cell differentiation.

J. Taipale, J. Keski‐Oja, S. Matikainen, 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Enhanced production of plasminogen activator activity in human and murine keratinocytes by transforming growth factor-beta 1.

J. Keski‐Oja, K. Koli, J. Keski‐oja, 1992, The Journal of investigative dermatology.

Biological effects of transforming growth factors

R. Coffey, H. Moses, J. Keski‐Oja, 1989 .

Characterization of a novel gelatin-binding 21 kDa protein secreted by cultured adherent cells.

M. Laiho, J. Keski‐Oja, T. Vartio, 1986, Biochimica et biophysica acta.

Sequential deposition of latent TGF-beta binding proteins (LTBPs) during formation of the extracellular matrix in human lung fibroblasts.

J. Keski‐Oja, Katri Koli, Marko Hyytiäinen, 2005, Experimental cell research.

MT1-MMP promotes vascular smooth muscle dedifferentiation through LRP1 processing

S. Weiss, J. Keski‐Oja, K. Lehti, 2009, Journal of Cell Science.

Growth inhibitory polypeptides in the regulation of cell proliferation.

H. Moses, J. Keski‐Oja, J. Keski‐oja, 1987, Medical biology.

Motility of glioblastoma cells is driven by netrin-1 induced gain of stemness

P. Laakkonen, A. Laakso, J. Keski‐Oja, 2017, Journal of Experimental & Clinical Cancer Research.

EGF/EGFR upregulates and cooperates with Netrin-4 to protect glioblastoma cells from DNA damage-induced senescence

J. Keski‐Oja, Z. Du, Yulun Huang, 2018, BMC Cancer.

NETRIN-4 Protects Glioblastoma Cells FROM Temozolomide Induced Senescence

J. Keski‐Oja, Ping Chen, Yizhou Hu, 2013, PloS one.

Risk of hepatitis B in a ward for mentally retarded HBsAg carriers

J. Keski‐Oja, J. Eskola, S. Autio, 1986, Infection.

Independent Promoters Regulate the Expression of Two Amino Terminally Distinct Forms of Latent Transforming Growth Factor-β Binding Protein-1 (LTBP-1) in a Cell Type-specific Manner*

J. Keski‐Oja, J. Saharinen, C. Koski, 1999, The Journal of Biological Chemistry.

Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells.

L. Chow, J. Keski‐Oja, K. Tryggvason, 1991, The Journal of biological chemistry.

Interaction of viral envelope glycoproteins with fibronectin

J. Keski‐Oja, I. Julkunen, A. Hautanen, 1983, Infection and immunity.

TGF-beta 1 modulation of urokinase and PAI-1 expression in human bronchial epithelial cells.

C. Harris, J. Lechner, J. Keski‐Oja, 1990, The American journal of physiology.

Establishment and characterization of the epithelial mouse embryo cell line MMC-E.

U. Heine, U. Rapp, J. Keski‐Oja, 1979, Cancer research.

Affinity of myeloma IgG proteins for fibronectin.

J. Keski‐Oja, A. Hautanen, 1983, Clinical and experimental immunology.

Binding of endostatin to phosphatidylserine-containing membranes and formation of amyloid-like fibers.

P. Kinnunen, J. Keski‐Oja, S. Wickström, 2005, Biochemistry.

C3c and C3d fragments of human C3 bind myeloma IgG1 and IgG3 proteins.

J. Keski‐Oja, A. Hautanen, A. Sarnesto, 1982, Immunology letters.

MMC-E cells--origin and changes in karyotype accompanying malignant transformation.

S. Knuutila, U. Rapp, J. Keski‐Oja, 1985, Cancer genetics and cytogenetics.

Distribution of the 36 000 dalton tyrosine protein kinase substrate in drug and epidermal growth factor-treated epithelial cells.

K. Alitalo, J. Keski‐Oja, R. Ralston, 1984, Experimental cell research.

Keratin filaments of mouse epithelial cells are rapidly affected by epidermal growth factor

J. Keski‐Oja, V. Lehto, I. Virtanen, 1981, The Journal of cell biology.

Epidermal growth factor-induced alterations in proliferating mouse epithelial cells.

U. Heine, U. Rapp, J. Keski‐Oja, 1980, Experimental cell research.

Single-serum radial hemolysis to detect recent rubella virus infection.

J. Keski‐Oja, K. Hedman, E. Salonen, 1986, The Journal of infectious diseases.

35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts.

Thomas J. Smith, B. M. Rasmussen, V. C. Phan, 1999, Diabetologia.

The cellular response to induction of the p21 c‐Ha‐ras oncoprotein includes stimulation of jun gene expression.

K. Alitalo, T. Mäkelä, L. Sistonen, 1989, The EMBO journal.

Secretion of active membrane type 1 matrix metalloproteinase (MMP‐14) into extracellular space in microvesicular exosomes

J. Keski‐Oja, K. Lehti, Kaisa Lehti, 2008, Journal of cellular biochemistry.

Fibroblast growth factor receptor 4 regulates tumor invasion by coupling fibroblast growth factor signaling to extracellular matrix degradation.

O. Kallioniemi, O. Kallioniemi, K. Alitalo, 2010 .

TGF-beta activation by traction?

H. von Melchner, J. Keski‐Oja, K. Koli, 2004, Trends in cell biology.

Increased intravitreal angiopoietin-2 levels associated with rhegmatogenous retinal detachment

I. Immonen, J. Keski‐Oja, K. Lehti, 2014, Graefe's Archive for Clinical and Experimental Ophthalmology.

Transforming Growth Factor-i Increases Steady State Levels of Type I Procollagen and Fibronectin Messenger RNAs Posttranscriptionally in Cultured Human Dermal Fibroblasts

Postlethwaite, H. Moses, R. Raghow, 2013 .

EGF/EGFR upregulates and cooperates with Netrin-4 to protect glioblastoma cells from DNA damage-induced senescence

J. Keski‐Oja, Z. Du, Yulun Huang, 2018, BMC Cancer.

Matrix reloaded to circulation hits the tumor target.

K. Alitalo, J. Keski‐Oja, S. Wickström, 2003, Cancer cell.

Interaction of Fibronectin with Complement Component C3

J. Keski‐Oja, A. Hautanen, 1983, Scandinavian journal of immunology.

Membrane-Type-3 Matrix Metalloproteinase (MT3-MMP) Functions as a Matrix Composition-Dependent Effector of Melanoma Cell Invasion

S. Weiss, J. Keski‐Oja, K. Lehti, 2011, PloS one.

Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis

Stephen J. Weiss, Duanqing Pei, S. Weiss, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Transforming growth factor beta alters plasminogen activator activity in human skin fibroblasts.

M. Laiho, J. Keski‐Oja, O. Saksela, 1986, Experimental cell research.

Structural analysis and promoter characterization of the human membrane-type matrix metalloproteinase-1 (MT1-MMP) gene.

W. Parks, J. Keski‐Oja, K. Lehti, 2000, Gene.

Reorganization of plasma membrane-associated 36 000 dalton protein upon drug-induced redistribution of cytokeratin.

K. Alitalo, J. Keski‐Oja, J. Keski‐oja, 1985, Experimental cell research.

Fibroblast Growth Factor Receptor 4 Regulates Tumor Invasion by Coupling Fibroblast Growth Factor Signaling to

O. Kallioniemi, K. Alitalo, J. Taipale, 2010 .

Fibroblast growth factor receptor 4 regulates tumor invasion by coupling fibroblast growth factor signaling to extracellular matrix degradation.

Kari, J. Taipale, M. Varjosalo, 2010, Cancer research.

[Tetracyclines as anti-inflammatory treatment in skin diseases].

P. Autio, J. Keski‐Oja, 1996, Nordisk Medicin.

Binding of fibronectin to actin is inhibited by gelatin.

E. Engvall, E. Ruoslahti, J. Keski‐Oja, 1981, Biochemical and biophysical research communications.